varicella-3

BIOLOGICAL2 trials

Sponsors

Beijing Center for Disease Control and Prevention, Changchun Keygen Biological Products Co., Ltd.

Conditions

Varicella

Phase 4

The Safety and Immunogenicity Research of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination

Beijing Center for Disease Control and PreventionVaricella

Start: 2013-06-30End: 2016-01-31Target: 1800Updated: 2013-06-26

Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine

CompletedNCT02173899

Changchun Keygen Biological Products Co., Ltd.Varicella

Start: 2014-06-30End: 2014-08-31Updated: 2014-09-01